You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Alkem Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ALKEM, and what generic and branded alternatives to ALKEM drugs are available?

ALKEM has one hundred and thirty-four approved drugs.

There are nine tentative approvals on ALKEM drugs.

Summary for Alkem

US Patents:	0
Tradenames:	109
Ingredients:	108
NDAs:	134
Patent Litigation for Alkem:	See patent lawsuits for Alkem

Drugs and US Patents for Alkem

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alkem	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET;ORAL	091184-001	Nov 1, 2010	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Alkem Labs Ltd	IBUPROFEN	ibuprofen	TABLET;ORAL	214699-002	Sep 13, 2021	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Alkem Labs Ltd	CHOLESTYRAMINE LIGHT	cholestyramine	POWDER;ORAL	211799-001	Oct 19, 2021	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Alkem Labs Ltd	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE;ORAL	217248-004	Jun 20, 2023	AB1	RX	No	No		⤷ Subscribe				⤷ Subscribe
Alkem Labs Ltd	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET;ORAL	211779-002	Oct 4, 2019	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Alkem Labs Ltd	FINASTERIDE	finasteride	TABLET;ORAL	204304-001	Jan 5, 2017	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Alkem Labs Ltd	TIZANIDINE HYDROCHLORIDE	tizanidine hydrochloride	TABLET;ORAL	211798-001	Jan 25, 2019	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Alkem

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alkem Labs Ltd	MARINOL	dronabinol	CAPSULE;ORAL	018651-001	May 31, 1985	6,703,418	⤷ Subscribe
Alkem Labs Ltd	MARINOL	dronabinol	CAPSULE;ORAL	018651-003	May 31, 1985	6,703,418	⤷ Subscribe
Alkem Labs Ltd	MARINOL	dronabinol	CAPSULE;ORAL	018651-002	May 31, 1985	6,703,418	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.